| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nuclear receptor activity | 1.05e-08 | 60 | 25 | 5 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 1.14e-08 | 61 | 25 | 5 | GO:0098531 | |
| GeneOntologyMolecularFunction | nuclear steroid receptor activity | 3.92e-06 | 25 | 25 | 3 | GO:0003707 | |
| GeneOntologyMolecularFunction | retinoic acid-responsive element binding | 3.15e-05 | 7 | 25 | 2 | GO:0044323 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 4.36e-05 | 55 | 25 | 3 | GO:0042974 | |
| GeneOntologyMolecularFunction | estrogen response element binding | 8.22e-05 | 11 | 25 | 2 | GO:0034056 | |
| GeneOntologyMolecularFunction | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 1.16e-04 | 13 | 25 | 2 | GO:0001162 | |
| GeneOntologyMolecularFunction | CCR6 chemokine receptor binding | 1.16e-04 | 13 | 25 | 2 | GO:0031731 | |
| GeneOntologyMolecularFunction | intronic transcription regulatory region sequence-specific DNA binding | 2.02e-04 | 17 | 25 | 2 | GO:0001161 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 2.23e-04 | 1412 | 25 | 8 | GO:0000981 | |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 2.27e-04 | 18 | 25 | 2 | GO:0042809 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2.80e-04 | 1459 | 25 | 8 | GO:0000977 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 6.37e-04 | 1244 | 25 | 7 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 7.24e-04 | 1271 | 25 | 7 | GO:0000987 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 8.24e-04 | 34 | 25 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.60e-03 | 187 | 25 | 3 | GO:0016922 | |
| GeneOntologyMolecularFunction | chemoattractant activity | 2.07e-03 | 54 | 25 | 2 | GO:0042056 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.08e-03 | 749 | 25 | 5 | GO:0005509 | |
| GeneOntologyMolecularFunction | CCR chemokine receptor binding | 2.22e-03 | 56 | 25 | 2 | GO:0048020 | |
| GeneOntologyMolecularFunction | clathrin binding | 2.80e-03 | 63 | 25 | 2 | GO:0030276 | |
| GeneOntologyMolecularFunction | coreceptor activity | 3.65e-03 | 72 | 25 | 2 | GO:0015026 | |
| GeneOntologyMolecularFunction | zinc ion binding | 4.41e-03 | 891 | 25 | 5 | GO:0008270 | |
| GeneOntologyMolecularFunction | chemokine receptor binding | 4.59e-03 | 81 | 25 | 2 | GO:0042379 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 6.77e-03 | 616 | 25 | 4 | GO:0030545 | |
| GeneOntologyBiologicalProcess | prostate gland epithelium morphogenesis | 8.38e-06 | 33 | 25 | 3 | GO:0060740 | |
| GeneOntologyBiologicalProcess | prostate gland morphogenesis | 9.18e-06 | 34 | 25 | 3 | GO:0060512 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 1.29e-05 | 38 | 25 | 3 | GO:0048384 | |
| GeneOntologyBiologicalProcess | positive regulation of vitamin D receptor signaling pathway | 2.11e-05 | 6 | 25 | 2 | GO:0070564 | |
| GeneOntologyBiologicalProcess | positive regulation of bone mineralization | 2.79e-05 | 49 | 25 | 3 | GO:0030501 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | 2.98e-05 | 1450 | 25 | 9 | GO:1901701 | |
| GeneOntologyBiologicalProcess | positive regulation of biomineral tissue development | 5.14e-05 | 60 | 25 | 3 | GO:0070169 | |
| GeneOntologyBiologicalProcess | prostate gland development | 5.67e-05 | 62 | 25 | 3 | GO:0030850 | |
| GeneOntologyBiologicalProcess | regulation of vitamin D receptor signaling pathway | 6.31e-05 | 10 | 25 | 2 | GO:0070562 | |
| GeneOntologyBiologicalProcess | positive regulation of ossification | 6.84e-05 | 66 | 25 | 3 | GO:0045778 | |
| GeneOntologyBiologicalProcess | regulation of myelination | 7.16e-05 | 67 | 25 | 3 | GO:0031641 | |
| GeneOntologyBiologicalProcess | vitamin D receptor signaling pathway | 9.24e-05 | 12 | 25 | 2 | GO:0070561 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 9.61e-05 | 202 | 25 | 4 | GO:0141193 | |
| GeneOntologyBiologicalProcess | positive chemotaxis | 1.00e-04 | 75 | 25 | 3 | GO:0050918 | |
| GeneOntologyBiologicalProcess | urogenital system development | 1.17e-04 | 79 | 25 | 3 | GO:0001655 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 1.24e-04 | 416 | 25 | 5 | GO:0030522 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in prostate gland development | 1.47e-04 | 15 | 25 | 2 | GO:0060742 | |
| GeneOntologyBiologicalProcess | regulation of bone mineralization | 1.78e-04 | 91 | 25 | 3 | GO:0030500 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 1.84e-04 | 239 | 25 | 4 | GO:0071383 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 1.87e-04 | 727 | 25 | 6 | GO:0032870 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 1.99e-04 | 244 | 25 | 4 | GO:0009755 | |
| GeneOntologyBiologicalProcess | cellular response to lipid | 2.19e-04 | 748 | 25 | 6 | GO:0071396 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell differentiation | 2.38e-04 | 19 | 25 | 2 | GO:0055012 | |
| GeneOntologyBiologicalProcess | striated muscle cell proliferation | 3.12e-04 | 110 | 25 | 3 | GO:0014855 | |
| GeneOntologyBiologicalProcess | regulation of biomineral tissue development | 3.46e-04 | 114 | 25 | 3 | GO:0070167 | |
| GeneOntologyBiologicalProcess | cellular response to vitamin D | 3.51e-04 | 23 | 25 | 2 | GO:0071305 | |
| GeneOntologyBiologicalProcess | defense response to Gram-negative bacterium | 3.93e-04 | 119 | 25 | 3 | GO:0050829 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 3.93e-04 | 1186 | 25 | 7 | GO:0007167 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol efflux | 4.86e-04 | 27 | 25 | 2 | GO:0010875 | |
| GeneOntologyBiologicalProcess | response to retinoic acid | 5.20e-04 | 131 | 25 | 3 | GO:0032526 | |
| GeneOntologyBiologicalProcess | negative regulation of transforming growth factor beta receptor signaling pathway | 6.05e-04 | 138 | 25 | 3 | GO:0030512 | |
| GeneOntologyBiologicalProcess | muscle cell proliferation | 6.17e-04 | 329 | 25 | 4 | GO:0033002 | |
| GeneOntologyBiologicalProcess | cellular response to vitamin | 6.42e-04 | 31 | 25 | 2 | GO:0071295 | |
| GeneOntologyBiologicalProcess | regulation of ossification | 7.27e-04 | 147 | 25 | 3 | GO:0030278 | |
| GeneOntologyBiologicalProcess | bone mineralization | 7.56e-04 | 149 | 25 | 3 | GO:0030282 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 8.07e-04 | 625 | 25 | 5 | GO:0051960 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 8.48e-04 | 155 | 25 | 3 | GO:0043401 | |
| GeneOntologyBiologicalProcess | response to vitamin D | 9.65e-04 | 38 | 25 | 2 | GO:0033280 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 1.02e-03 | 1390 | 25 | 7 | GO:0045944 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 1.07e-03 | 381 | 25 | 4 | GO:0048545 | |
| GeneOntologyBiologicalProcess | positive regulation of sterol transport | 1.07e-03 | 40 | 25 | 2 | GO:0032373 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol transport | 1.07e-03 | 40 | 25 | 2 | GO:0032376 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 1.26e-03 | 178 | 25 | 3 | GO:0022612 | |
| GeneOntologyBiologicalProcess | response to hormone | 1.27e-03 | 1042 | 25 | 6 | GO:0009725 | |
| GeneOntologyBiologicalProcess | maternal placenta development | 1.29e-03 | 44 | 25 | 2 | GO:0001893 | |
| GeneOntologyBiologicalProcess | regulation of response to nutrient levels | 1.41e-03 | 46 | 25 | 2 | GO:0032107 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 1.57e-03 | 192 | 25 | 3 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 1.64e-03 | 195 | 25 | 3 | GO:1903844 | |
| GeneOntologyBiologicalProcess | placenta development | 1.69e-03 | 197 | 25 | 3 | GO:0001890 | |
| GeneOntologyBiologicalProcess | mRNA transcription by RNA polymerase II | 1.80e-03 | 52 | 25 | 2 | GO:0042789 | |
| GeneOntologyBiologicalProcess | biomineral tissue development | 1.84e-03 | 203 | 25 | 3 | GO:0031214 | |
| GeneOntologyBiologicalProcess | response to lipid | 1.89e-03 | 1126 | 25 | 6 | GO:0033993 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.89e-03 | 445 | 25 | 4 | GO:0141091 | |
| GeneOntologyBiologicalProcess | myelination | 1.92e-03 | 206 | 25 | 3 | GO:0042552 | |
| GeneOntologyBiologicalProcess | ensheathment of neurons | 2.00e-03 | 209 | 25 | 3 | GO:0007272 | |
| GeneOntologyBiologicalProcess | axon ensheathment | 2.00e-03 | 209 | 25 | 3 | GO:0008366 | |
| GeneOntologyBiologicalProcess | cellular response to nutrient | 2.01e-03 | 55 | 25 | 2 | GO:0031670 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol efflux | 2.09e-03 | 56 | 25 | 2 | GO:0010874 | |
| GeneOntologyBiologicalProcess | mRNA transcription | 2.16e-03 | 57 | 25 | 2 | GO:0009299 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.26e-03 | 218 | 25 | 3 | GO:0090101 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 2.52e-03 | 482 | 25 | 4 | GO:0007178 | |
| GeneOntologyBiologicalProcess | chemotaxis | 3.25e-03 | 517 | 25 | 4 | GO:0006935 | |
| GeneOntologyBiologicalProcess | muscle structure development | 3.27e-03 | 858 | 25 | 5 | GO:0061061 | |
| GeneOntologyBiologicalProcess | female pregnancy | 3.29e-03 | 249 | 25 | 3 | GO:0007565 | |
| GeneOntologyBiologicalProcess | taxis | 3.29e-03 | 519 | 25 | 4 | GO:0042330 | |
| GeneOntologyBiologicalProcess | maternal process involved in female pregnancy | 3.52e-03 | 73 | 25 | 2 | GO:0060135 | |
| GeneOntologyBiologicalProcess | cellular response to retinoic acid | 3.52e-03 | 73 | 25 | 2 | GO:0071300 | |
| GeneOntologyBiologicalProcess | organ growth | 3.55e-03 | 256 | 25 | 3 | GO:0035265 | |
| GeneOntologyBiologicalProcess | cholesterol efflux | 3.90e-03 | 77 | 25 | 2 | GO:0033344 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 4.27e-03 | 558 | 25 | 4 | GO:0060537 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 4.38e-03 | 276 | 25 | 3 | GO:0007179 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell proliferation | 4.41e-03 | 82 | 25 | 2 | GO:0060038 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 4.52e-03 | 83 | 25 | 2 | GO:0060976 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol transport | 4.52e-03 | 83 | 25 | 2 | GO:0032374 | |
| GeneOntologyBiologicalProcess | regulation of sterol transport | 4.52e-03 | 83 | 25 | 2 | GO:0032371 | |
| Domain | zf-C4 | 2.97e-09 | 46 | 24 | 5 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 2.97e-09 | 46 | 24 | 5 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 2.97e-09 | 46 | 24 | 5 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 2.97e-09 | 46 | 24 | 5 | IPR001723 | |
| Domain | ZnF_C4 | 2.97e-09 | 46 | 24 | 5 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 2.97e-09 | 46 | 24 | 5 | PS51030 | |
| Domain | - | 3.32e-09 | 47 | 24 | 5 | 1.10.565.10 | |
| Domain | HOLI | 3.71e-09 | 48 | 24 | 5 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 3.71e-09 | 48 | 24 | 5 | IPR000536 | |
| Domain | Hormone_recep | 3.71e-09 | 48 | 24 | 5 | PF00104 | |
| Domain | - | 9.00e-09 | 57 | 24 | 5 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 9.84e-09 | 58 | 24 | 5 | IPR013088 | |
| Domain | EGF_CA | 1.66e-05 | 122 | 24 | 4 | SM00179 | |
| Domain | EGF-like_CS | 1.75e-05 | 261 | 24 | 5 | IPR013032 | |
| Domain | EGF-like_Ca-bd_dom | 1.77e-05 | 124 | 24 | 4 | IPR001881 | |
| Domain | EGF_2 | 1.89e-05 | 265 | 24 | 5 | PS01186 | |
| Domain | Growth_fac_rcpt_ | 4.37e-05 | 156 | 24 | 4 | IPR009030 | |
| Domain | Retinoid-X_rcpt/HNF4 | 7.08e-05 | 10 | 24 | 2 | IPR000003 | |
| Domain | Defensin_beta | 1.04e-04 | 12 | 24 | 2 | PF00711 | |
| Domain | Defensin_beta-typ | 1.04e-04 | 12 | 24 | 2 | IPR001855 | |
| Domain | VitD_rcpt | 1.43e-04 | 14 | 24 | 2 | IPR000324 | |
| Domain | EGF_CA | 1.78e-04 | 86 | 24 | 3 | PF07645 | |
| Domain | EGF_3 | 2.13e-04 | 235 | 24 | 4 | PS50026 | |
| Domain | EGF | 2.13e-04 | 235 | 24 | 4 | SM00181 | |
| Domain | EGF_Ca-bd_CS | 2.54e-04 | 97 | 24 | 3 | IPR018097 | |
| Domain | EGF-like_dom | 2.66e-04 | 249 | 24 | 4 | IPR000742 | |
| Domain | EGF_CA | 2.70e-04 | 99 | 24 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.78e-04 | 100 | 24 | 3 | PS00010 | |
| Domain | EGF_1 | 2.91e-04 | 255 | 24 | 4 | PS00022 | |
| Domain | zf-MYND | 3.27e-04 | 21 | 24 | 2 | PF01753 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.30e-04 | 106 | 24 | 3 | IPR000152 | |
| Domain | Znf_MYND | 3.60e-04 | 22 | 24 | 2 | IPR002893 | |
| Domain | ZF_MYND_1 | 3.60e-04 | 22 | 24 | 2 | PS01360 | |
| Domain | ZF_MYND_2 | 3.60e-04 | 22 | 24 | 2 | PS50865 | |
| Domain | cEGF | 5.05e-04 | 26 | 24 | 2 | IPR026823 | |
| Domain | cEGF | 5.05e-04 | 26 | 24 | 2 | PF12662 | |
| Domain | zf-C2H2 | 1.64e-03 | 693 | 24 | 5 | PF00096 | |
| Domain | ZINC_FINGER_C2H2_2 | 2.67e-03 | 775 | 24 | 5 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 2.70e-03 | 777 | 24 | 5 | PS00028 | |
| Domain | Znf_C2H2-like | 3.00e-03 | 796 | 24 | 5 | IPR015880 | |
| Domain | Znf_C2H2 | 3.15e-03 | 805 | 24 | 5 | IPR007087 | |
| Domain | ZnF_C2H2 | 3.20e-03 | 808 | 24 | 5 | SM00355 | |
| Domain | - | 1.03e-02 | 679 | 24 | 4 | 3.30.160.60 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 1.11e-02 | 694 | 24 | 4 | IPR013087 | |
| Domain | EGF | 1.13e-02 | 126 | 24 | 2 | PF00008 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 5.51e-09 | 48 | 20 | 5 | MM14987 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 9.20e-09 | 53 | 20 | 5 | M8276 | |
| Pathway | WP_VITAMIN_A1_AND_A5X_PATHWAYS | 4.87e-08 | 6 | 20 | 3 | M48097 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 2.11e-07 | 38 | 20 | 4 | MM15865 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 2.11e-07 | 38 | 20 | 4 | M39657 | |
| Pathway | PID_RXR_VDR_PATHWAY | 6.22e-06 | 26 | 20 | 3 | M162 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 9.68e-06 | 30 | 20 | 3 | M207 | |
| Pathway | KEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION | 1.91e-05 | 5 | 20 | 2 | M49023 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS | 1.91e-05 | 5 | 20 | 2 | M29812 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE | 1.91e-05 | 5 | 20 | 2 | M29791 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE | 1.91e-05 | 5 | 20 | 2 | M29792 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 2.86e-05 | 6 | 20 | 2 | MM15663 | |
| Pathway | REACTOME_BETA_DEFENSINS | 2.91e-05 | 43 | 20 | 3 | M565 | |
| Pathway | WP_VITAMIN_A_AND_CAROTENOID_METABOLISM | 2.91e-05 | 43 | 20 | 3 | M39554 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 2.91e-05 | 43 | 20 | 3 | M27443 | |
| Pathway | WP_RETINOL_METABOLISM | 3.12e-05 | 44 | 20 | 3 | MM15851 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 4.32e-05 | 49 | 20 | 3 | MM15186 | |
| Pathway | REACTOME_DEFENSINS | 5.47e-05 | 53 | 20 | 3 | M557 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 6.84e-05 | 9 | 20 | 2 | M29809 | |
| Pathway | KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY | 6.84e-05 | 9 | 20 | 2 | M47629 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS | 6.84e-05 | 9 | 20 | 2 | M29789 | |
| Pathway | WP_VITAMIN_D_METABOLISM | 8.55e-05 | 10 | 20 | 2 | M39352 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.33e-04 | 191 | 20 | 4 | MM15586 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.48e-04 | 13 | 20 | 2 | MM15622 | |
| Pathway | REACTOME_ANTIMICROBIAL_PEPTIDES | 3.41e-04 | 98 | 20 | 3 | M27627 | |
| Pathway | REACTOME_BETA_DEFENSINS | 3.58e-04 | 20 | 20 | 2 | MM14567 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 7.08e-04 | 296 | 20 | 4 | M27869 | |
| Pathway | KEGG_THYROID_CANCER | 7.59e-04 | 29 | 20 | 2 | M523 | |
| Pathway | REACTOME_DEFENSINS | 8.68e-04 | 31 | 20 | 2 | MM14568 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 1.24e-03 | 37 | 20 | 2 | M29790 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.91e-03 | 46 | 20 | 2 | M239 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.99e-03 | 47 | 20 | 2 | M29777 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 2.15e-03 | 1387 | 20 | 7 | M734 | |
| Pathway | PID_AR_TF_PATHWAY | 2.52e-03 | 53 | 20 | 2 | M151 | |
| Pathway | KEGG_NON_SMALL_CELL_LUNG_CANCER | 2.62e-03 | 54 | 20 | 2 | M19818 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 3.70e-03 | 768 | 20 | 5 | MM14851 | |
| Pathway | WP_PPAR_SIGNALING | 4.00e-03 | 67 | 20 | 2 | M39553 | |
| Pathway | KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY | 4.00e-03 | 67 | 20 | 2 | M10462 | |
| Pathway | KEGG_PPAR_SIGNALING_PATHWAY | 4.24e-03 | 69 | 20 | 2 | M13088 | |
| Pathway | REACTOME_ANTIMICROBIAL_PEPTIDES | 4.36e-03 | 70 | 20 | 2 | MM15332 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 4.61e-03 | 72 | 20 | 2 | M39738 | |
| Pathway | WP_PPAR_SIGNALING_PATHWAY | 4.73e-03 | 73 | 20 | 2 | MM15995 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 4.99e-03 | 75 | 20 | 2 | M39568 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 6.22e-03 | 84 | 20 | 2 | M3228 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 8.05e-03 | 96 | 20 | 2 | M39834 | |
| Pubmed | 1.31e-09 | 4 | 25 | 3 | 1310259 | ||
| Pubmed | Nuclear receptors in Leydig cell gene expression and function. | 1.51e-09 | 22 | 25 | 4 | 20375256 | |
| Pubmed | Developmental expression of murine retinoid X receptor (RXR) genes. | 3.28e-09 | 5 | 25 | 3 | 8199055 | |
| Pubmed | 3.28e-09 | 5 | 25 | 3 | 9053308 | ||
| Pubmed | The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development. | 6.55e-09 | 6 | 25 | 3 | 9806918 | |
| Pubmed | Systematic immunolocalization of retinoid receptors in developing and adult mouse eyes. | 6.55e-09 | 6 | 25 | 3 | 11328745 | |
| Pubmed | 6.55e-09 | 6 | 25 | 3 | 16751185 | ||
| Pubmed | A genetic dissection of the retinoid signalling pathway in the mouse. | 6.55e-09 | 6 | 25 | 3 | 10604193 | |
| Pubmed | 6.55e-09 | 6 | 25 | 3 | 9153406 | ||
| Pubmed | Spatial distributions of retinoic acid receptor gene transcripts in the prenatal mouse inner ear. | 6.55e-09 | 6 | 25 | 3 | 9548551 | |
| Pubmed | Functional specificity of the two retinoic acid receptor RAR and RXR families in myogenesis. | 6.55e-09 | 6 | 25 | 3 | 9464546 | |
| Pubmed | 6.55e-09 | 6 | 25 | 3 | 9075714 | ||
| Pubmed | Inflammatory chemokine release of astrocytes in vitro is reduced by all-trans retinoic acid. | 6.55e-09 | 6 | 25 | 3 | 20557428 | |
| Pubmed | 6.55e-09 | 6 | 25 | 3 | 8801169 | ||
| Pubmed | 6.55e-09 | 6 | 25 | 3 | 8801176 | ||
| Pubmed | 1.15e-08 | 7 | 25 | 3 | 17195188 | ||
| Pubmed | Differential contributions of AF-1 and AF-2 activities to the developmental functions of RXR alpha. | 1.15e-08 | 7 | 25 | 3 | 11493527 | |
| Pubmed | 1.15e-08 | 7 | 25 | 3 | 10406480 | ||
| Pubmed | 1.15e-08 | 7 | 25 | 3 | 12360493 | ||
| Pubmed | 1.15e-08 | 7 | 25 | 3 | 15635645 | ||
| Pubmed | 1.15e-08 | 7 | 25 | 3 | 8090775 | ||
| Pubmed | Expression of nuclear retinoic acid receptors during mouse odontogenesis. | 1.83e-08 | 8 | 25 | 3 | 7988794 | |
| Pubmed | Retinoids and adipose tissues: metabolism, cell differentiation and gene expression. | 1.83e-08 | 8 | 25 | 3 | 10094571 | |
| Pubmed | Prepubertal testis development relies on retinoic acid but not rexinoid receptors in Sertoli cells. | 1.83e-08 | 8 | 25 | 3 | 17124491 | |
| Pubmed | 2.08e-08 | 118 | 25 | 5 | 16971476 | ||
| Pubmed | 5.39e-08 | 11 | 25 | 3 | 29093497 | ||
| Pubmed | 6.91e-08 | 55 | 25 | 4 | 34292881 | ||
| Pubmed | 7.19e-08 | 12 | 25 | 3 | 9022057 | ||
| Pubmed | 7.19e-08 | 12 | 25 | 3 | 26427057 | ||
| Pubmed | 1.19e-07 | 14 | 25 | 3 | 18561907 | ||
| Pubmed | 1.19e-07 | 14 | 25 | 3 | 18393306 | ||
| Pubmed | 1.19e-07 | 14 | 25 | 3 | 21923909 | ||
| Pubmed | 1.48e-07 | 15 | 25 | 3 | 9267036 | ||
| Pubmed | 1.48e-07 | 15 | 25 | 3 | 19448158 | ||
| Pubmed | 1.83e-07 | 16 | 25 | 3 | 25577283 | ||
| Pubmed | 1.83e-07 | 16 | 25 | 3 | 11795391 | ||
| Pubmed | 3.71e-07 | 20 | 25 | 3 | 19605690 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 33246082 | ||
| Pubmed | RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. | 4.96e-07 | 2 | 25 | 2 | 7926783 | |
| Pubmed | Endogenous retinoid X receptor ligands in mouse hematopoietic cells. | 4.96e-07 | 2 | 25 | 2 | 29089448 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 28886438 | ||
| Pubmed | Retinoic acid inhibition of IL-1-induced IL-6 production by human lung fibroblasts. | 4.96e-07 | 2 | 25 | 2 | 8301142 | |
| Pubmed | Three retinoid X receptor gene polymorphisms in plaque psoriasis and psoriasis guttata. | 4.96e-07 | 2 | 25 | 2 | 17341859 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 10919981 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 9083083 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 24080207 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 16199515 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 24810760 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 11855864 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 8780715 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 20798333 | ||
| Pubmed | A transcriptionally silent RXRalpha supports early embryonic morphogenesis and heart development. | 4.96e-07 | 2 | 25 | 2 | 19255444 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 22316320 | ||
| Pubmed | 5.01e-07 | 22 | 25 | 3 | 10753524 | ||
| Pubmed | 5.76e-07 | 23 | 25 | 3 | 19737349 | ||
| Pubmed | Diverse Functions of Retinoic Acid in Brain Vascular Development. | 1.06e-06 | 28 | 25 | 3 | 27445154 | |
| Pubmed | Retinoid X receptors: X-ploring their (patho)physiological functions. | 1.49e-06 | 3 | 25 | 2 | 15608692 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 9442090 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 8034312 | ||
| Pubmed | RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes. | 1.49e-06 | 3 | 25 | 2 | 9491782 | |
| Pubmed | Unique response pathways are established by allosteric interactions among nuclear hormone receptors. | 1.49e-06 | 3 | 25 | 2 | 7758108 | |
| Pubmed | RXR heterodimers orchestrate transcriptional control of neurogenesis and cell fate specification. | 1.49e-06 | 3 | 25 | 2 | 28778663 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 9727070 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 7831303 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 8631847 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 19188585 | ||
| Pubmed | Retinoid receptors trigger neuritogenesis in retinal degenerations. | 1.49e-06 | 3 | 25 | 2 | 21940995 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 7990953 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 11839661 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 14705796 | ||
| Pubmed | Retinoid receptors in gastric cancer: expression and influence on prognosis. | 1.49e-06 | 3 | 25 | 2 | 22901127 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 27184385 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 12824162 | ||
| Pubmed | Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. | 1.49e-06 | 3 | 25 | 2 | 1312497 | |
| Pubmed | Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. | 1.49e-06 | 3 | 25 | 2 | 19897601 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 18375961 | ||
| Pubmed | Detection of retinoid X receptors using specific monoclonal and polyclonal antibodies. | 1.49e-06 | 3 | 25 | 2 | 7980510 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 18217139 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 10049761 | ||
| Pubmed | Immunohistochemical detection of the retinoid X receptors alpha, beta, and gamma in human prostate. | 1.49e-06 | 3 | 25 | 2 | 12514092 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 11053444 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 8799145 | ||
| Pubmed | 1.60e-06 | 32 | 25 | 3 | 17270348 | ||
| Pubmed | Regulation of prefrontal patterning and connectivity by retinoic acid. | 1.93e-06 | 34 | 25 | 3 | 34599305 | |
| Pubmed | Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. | 2.43e-06 | 133 | 25 | 4 | 15604093 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 2.57e-06 | 908 | 25 | 7 | 19274049 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 10594021 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 8670810 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 12093741 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 9804293 | ||
| Pubmed | Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. | 2.97e-06 | 4 | 25 | 2 | 7481822 | |
| Pubmed | Retinoic acid biosynthetic activity and retinoid receptors in the olfactory mucosa of adult mice. | 2.97e-06 | 4 | 25 | 2 | 10079186 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 8524212 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 7923367 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 32246014 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 7967725 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 26355550 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 10611353 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 12549917 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 9376317 | ||
| Interaction | NCOA1 interactions | 8.81e-07 | 146 | 25 | 5 | int:NCOA1 | |
| Interaction | NR0B2 interactions | 3.17e-06 | 83 | 25 | 4 | int:NR0B2 | |
| Interaction | TGIF1 interactions | 1.74e-05 | 41 | 25 | 3 | int:TGIF1 | |
| Interaction | NR2F6 interactions | 2.47e-05 | 46 | 25 | 3 | int:NR2F6 | |
| Interaction | RARB interactions | 2.47e-05 | 46 | 25 | 3 | int:RARB | |
| Interaction | RARG interactions | 4.97e-05 | 58 | 25 | 3 | int:RARG | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p12 | 2.72e-03 | 142 | 25 | 2 | chr6p12 | |
| GeneFamily | Nuclear hormone receptors | 1.34e-09 | 49 | 19 | 5 | 71 | |
| GeneFamily | Defensins, beta | 1.55e-05 | 47 | 19 | 3 | 503 | |
| GeneFamily | Zinc fingers MYND-type | 2.17e-04 | 21 | 19 | 2 | 87 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 7.12e-04 | 718 | 19 | 5 | 28 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_200 | 6.57e-05 | 67 | 25 | 3 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_100 | 1.24e-04 | 83 | 25 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | 1.58e-04 | 90 | 25 | 3 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_100 | 1.79e-04 | 17 | 25 | 2 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_100_k4 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-05 | 143 | 25 | 3 | 6df16bf0324661cd9707df69cb39f4b5498d6d49 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.58e-05 | 160 | 25 | 3 | 0544bc465af208da448858d6e174ff56f2e08a46 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.94e-05 | 162 | 25 | 3 | 768a566e76923323c1f197f60bab472a8784490b | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-04 | 166 | 25 | 3 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 169 | 25 | 3 | e68e6c24606fd46eca6f86bb63fa86ea17879ae2 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-04 | 176 | 25 | 3 | 1510cdfcfb46ce1196a1220c07fb5f3986c81b78 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 176 | 25 | 3 | 450c25ec5eeb65425f904e0a25aaafdf5682ef9c | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.47e-04 | 185 | 25 | 3 | f4588468e8654363f48adbe427dff10f16f1c7fe | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.47e-04 | 185 | 25 | 3 | 3cb816fc9541c04b4436e21d984216cfbbacff98 | |
| ToppCell | BAL-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.47e-04 | 185 | 25 | 3 | c2e70405969616c28fb6379ee318e17bbcef7b49 | |
| ToppCell | Mild-Lymphoid-pDC|Mild / Condition, Lineage, Cell class and cell subclass | 1.50e-04 | 186 | 25 | 3 | 7fa82972c726025d6402e5eb7bf0db3b699eba4c | |
| ToppCell | BAL-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.50e-04 | 186 | 25 | 3 | d2fbf53aac905c9896272ec5c2db28ee1a60f4be | |
| ToppCell | Mild-Lymphoid-pDC-|Mild / Condition, Lineage, Cell class and cell subclass | 1.50e-04 | 186 | 25 | 3 | 1d05e73ae2ec0cc27f79e4fa40d6b21790059f80 | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.50e-04 | 186 | 25 | 3 | 79aedd5aed72509a4925e9f6cb43bc0c798c86f5 | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.50e-04 | 186 | 25 | 3 | b031f4e6867b6200b85f43276a34749bf5f4603f | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK-NK_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.52e-04 | 187 | 25 | 3 | 3301e0fca8c436d136c71f1a8fd59b3bb11bdd83 | |
| ToppCell | Mild_COVID-19-Myeloid-pDC|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.52e-04 | 187 | 25 | 3 | 99c3c4a7b9179dce7982dc6516d561c952abc80e | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-04 | 192 | 25 | 3 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 193 | 25 | 3 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 193 | 25 | 3 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-04 | 193 | 25 | 3 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.72e-04 | 195 | 25 | 3 | 580ed65b4152483b642a7e7dbdf00d03588c46f6 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.77e-04 | 197 | 25 | 3 | b91016249b3585aa3536e96af18e4f1b1d2d5ce4 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-04 | 197 | 25 | 3 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.77e-04 | 197 | 25 | 3 | ec46aa307ce5774b4c0fcba64514f2d0cab3c4f9 | |
| ToppCell | mLN-(4)_Monocyte-(40)_Monocyte|mLN / shred on region, Cell_type, and subtype | 1.82e-04 | 199 | 25 | 3 | bcbb1eee8d79bf670dbe113094c3a292b135ce2f | |
| ToppCell | mLN-(4)_Monocyte|mLN / shred on region, Cell_type, and subtype | 1.82e-04 | 199 | 25 | 3 | 6795ff31f92580195c9db776951f99d647484d24 | |
| ToppCell | mLN-Monocyte|mLN / Region, Cell class and subclass | 1.82e-04 | 199 | 25 | 3 | 241f790cd5d8a9b2451333deecc826a673bae70a | |
| ToppCell | mLN-Monocyte-Monocyte|mLN / Region, Cell class and subclass | 1.82e-04 | 199 | 25 | 3 | dcee372774c169a3048bdaed3734b3215bf8ffad | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.85e-04 | 200 | 25 | 3 | 107a0665fb20247511a430178effd7630a619488 | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.85e-04 | 200 | 25 | 3 | 9e3e13a68bc1110fa000ec2d80f4c654ddbce17e | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Nnat_(Neuron.Slc17a7.Syt6-Nnat)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.49e-04 | 62 | 25 | 2 | dd2e222d454fb78fed8b37901cbf04c0080ed010 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Nnat_(Neuron.Slc17a7.Syt6-Nnat)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.49e-04 | 62 | 25 | 2 | 6a3f990e8d59392ad909634a239b3ab4f13d8855 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Prlr_(Entorhinal_cortex?)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.03e-04 | 65 | 25 | 2 | 57d0d892dab8bc8465067feeff279c967a43b781 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Prlr_(Entorhinal_cortex?)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.03e-04 | 65 | 25 | 2 | aba26f607f35c2920cdf956309285ad9e7b758a7 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Slc17a6-Inhibitory_Neuron.Slc17a6-Gad1Gad2.Asb4_(Periventricular_Fiber_System_(Pv))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.26e-03 | 94 | 25 | 2 | be1dcfe287f58d608ccdb47cf9c1d12b5e3aa60d | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Slc17a6|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.26e-03 | 94 | 25 | 2 | 576c37fa53fab679f5e8786f5c798e18998186e9 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Slc17a6-Inhibitory_Neuron.Slc17a6-Gad1Gad2.Asb4_(Periventricular_Fiber_System_(Pv))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.26e-03 | 94 | 25 | 2 | 82e9178c848468497295c4cc59c662b9279208a1 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-03 | 103 | 25 | 2 | eb9f008b5fb8a01df8ea4faf6e6aebc1a9db9bd3 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-03 | 108 | 25 | 2 | ee924deacd14ea404fda80ed633960143fd474c0 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-03 | 122 | 25 | 2 | a2f343962069253a08faa80fd70723b8488a99ec | |
| ToppCell | TCGA-Testes|World / Sample_Type by Project: Shred V9 | 2.31e-03 | 128 | 25 | 2 | a09b0e221b8749510002304e4d34d6a2eb8867e9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-03 | 128 | 25 | 2 | 076ba9de63b9a4b5a2f7e7924b9a86e8eafce91f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-03 | 130 | 25 | 2 | 7d4319aae42acc914757796877b8f0d874acbec4 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-3|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 2.60e-03 | 136 | 25 | 2 | 4f5e0b6c7d6e3e922af4daa7c3eb56490455c1df | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.68e-03 | 138 | 25 | 2 | b63e26afafbd2cdeed9c9451e6f530ab6295504c | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.83e-03 | 142 | 25 | 2 | e160f35b3c18e77c4107fe96db5f56227c91785e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.83e-03 | 142 | 25 | 2 | 199a0a1024b6cc446f5ca1f277846a2bdb227a9f | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-03 | 143 | 25 | 2 | d877d914e4e74db2053baa310d318d6440e672bc | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic-Cycling_mono|bone_marrow / Manually curated celltypes from each tissue | 3.07e-03 | 148 | 25 | 2 | de35eeefad0e27a0d127e2e4bedead2bddb75152 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.07e-03 | 148 | 25 | 2 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.07e-03 | 148 | 25 | 2 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.19e-03 | 151 | 25 | 2 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.19e-03 | 151 | 25 | 2 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | PND01-03-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.27e-03 | 153 | 25 | 2 | 2482247d9c39c7b99bb45fb9153442f64fd6012f | |
| ToppCell | PND01-03-samps-Epithelial-Epithelial-non_alveolar|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.27e-03 | 153 | 25 | 2 | fc0d2d50aa3b6b2772bbf3626c9df5c5e8d7d11e | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.40e-03 | 156 | 25 | 2 | ffb9249a115ce31f50b99a7a3d40bf48b9d7f2b0 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 3.40e-03 | 156 | 25 | 2 | 19472ef1642c2ad333aa3ce3675a25c6ab1d4556 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-03 | 157 | 25 | 2 | 0966e347f8d32b13f8a3b3afba3f64637c69cdf9 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-03 | 157 | 25 | 2 | 6ebfedd91d62c6d4aa8f046657a899a279f82ba2 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.49e-03 | 158 | 25 | 2 | da060f5b61c7088f700d138b02ea596adacf7d60 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-03 | 158 | 25 | 2 | d3446fc98eff09c3626b47a2c90d07cd985378b5 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-03 | 158 | 25 | 2 | df614450e10629dc9115d7365397663e82f9e48f | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 3.49e-03 | 158 | 25 | 2 | ab05f6d7968ccd6d3826cd71b763dbedc83822c3 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.49e-03 | 158 | 25 | 2 | 2af7beb48272e5368d9ba6b80f08d47ab8556c08 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.49e-03 | 158 | 25 | 2 | 6d2709b387945c015faa223c20d22b52a4082140 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-03 | 159 | 25 | 2 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-03 | 159 | 25 | 2 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-tDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.53e-03 | 159 | 25 | 2 | 141c3ed35c7d11fcaec4acd9cb37104cc259db25 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-03 | 160 | 25 | 2 | 822adcf5f9208f305cafffd8ed97f3a061e82b03 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_GRIP2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-03 | 161 | 25 | 2 | b8c74ca839ce95ce97e3535086272f60a5135c52 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.62e-03 | 161 | 25 | 2 | 78cc5bc488bc47726195a649946d414e6bfabf94 | |
| ToppCell | BAL-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters | 3.62e-03 | 161 | 25 | 2 | 7a6e8ed0b5d999efce8945d8083ab01d71be9a92 | |
| ToppCell | normal-na-Lymphocytic_B-B_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.66e-03 | 162 | 25 | 2 | ae292318d339305932457bb0e91430594f7a3dfa | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.66e-03 | 162 | 25 | 2 | 34b4cd3d2258f88dfbd6d32abd1db87aff8a6b6f | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-03 | 162 | 25 | 2 | 76e289ad9fd3694f77fd0d19e74c1cb8e87b8094 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.66e-03 | 162 | 25 | 2 | 0fa93efc9c005d1e649b3f7069ae8641d6e41ed8 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.71e-03 | 163 | 25 | 2 | 3087224d3f16f5d3aecc3e1e4366220231afe31f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_PENK|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.71e-03 | 163 | 25 | 2 | 551b3788bcf494c6121e64ce5af72266de12a06b | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-03 | 164 | 25 | 2 | 2957065d7f1332c5280d47be7cc342286f84be3e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-GABAergic_neurons|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.75e-03 | 164 | 25 | 2 | 4d7b2d0980fb4f47721fa2891151e2bd892ccb91 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-03 | 164 | 25 | 2 | eae6d440877b292ad18dc4bd02802dda5b2f9c60 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.75e-03 | 164 | 25 | 2 | ed7e0c8ccad7d19b9cc72d70391936ff5e698f28 | |
| ToppCell | URO-Lymphocyte-T_NK-MAIT|URO / Disease, Lineage and Cell Type | 3.75e-03 | 164 | 25 | 2 | cb42a70433b3968caca67f7aa98ea536cd90a0bc | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-03 | 164 | 25 | 2 | 82e57d618c6e59bca4a03d31caf35b6043dfcf52 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.84e-03 | 166 | 25 | 2 | 8d5d09f25e8903d481c2097fed435e69d42ccdb5 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.84e-03 | 166 | 25 | 2 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.84e-03 | 166 | 25 | 2 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors|Liver / Manually curated celltypes from each tissue | 3.84e-03 | 166 | 25 | 2 | ae967570248cf86ca3ddf55e33bcbb3e4e3684bc | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Liver / Manually curated celltypes from each tissue | 3.84e-03 | 166 | 25 | 2 | a176e87aa6eec81d1fb79a028f759182d11b567d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.84e-03 | 166 | 25 | 2 | c8fd241088de27c6e741a5dfee3cd770183b6bcb | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-03 | 167 | 25 | 2 | 26cd8ee5e826e71eaf58d10a906543a6932fb3f9 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.88e-03 | 167 | 25 | 2 | 5accd0bc7c95089feb2c09376d12cd8bd3773775 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 3.88e-03 | 167 | 25 | 2 | 442ea71a581ed5a547a214132b9f1b0243fd0895 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-03 | 167 | 25 | 2 | b93103a868fba63a8910bffb690a6242b9252833 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-03 | 167 | 25 | 2 | b4ef07117d14da3d5fbced949e4dfcb01c392295 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.88e-03 | 167 | 25 | 2 | 99db8871c62336bd215efb65e969783d2b6003b0 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.88e-03 | 167 | 25 | 2 | 1e2fc1637769405a61f4c7e44945712a1888a299 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-03 | 167 | 25 | 2 | a813b95c2fafb638b249bc4fa4f708c6f39ad444 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-03 | 167 | 25 | 2 | 94fc7df7ca55cd722a8dbd153201a29891217473 | |
| Drug | Alitretinoin | 2.33e-08 | 6 | 25 | 3 | DB00523 | |
| Drug | Adapalene | 2.33e-08 | 6 | 25 | 3 | DB00210 | |
| Drug | Etretinate | 2.33e-08 | 6 | 25 | 3 | DB00926 | |
| Drug | Acitretin | 4.08e-08 | 7 | 25 | 3 | DB00459 | |
| Drug | AGN 191659 | 4.08e-08 | 7 | 25 | 3 | CID006366726 | |
| Drug | AGN 190121 | 4.08e-08 | 7 | 25 | 3 | CID006441236 | |
| Drug | HX 600 | 6.52e-08 | 8 | 25 | 3 | ctd:C104181 | |
| Drug | TTNN | 6.52e-08 | 8 | 25 | 3 | CID000135754 | |
| Drug | AGN 191701 | 1.92e-07 | 11 | 25 | 3 | CID006438168 | |
| Drug | UVI 3003 | 1.92e-07 | 11 | 25 | 3 | ctd:C525131 | |
| Drug | di-n-propylphthalate | 2.56e-07 | 12 | 25 | 3 | ctd:C106479 | |
| Drug | tazarotenic acid | 3.32e-07 | 13 | 25 | 3 | CID000147525 | |
| Drug | Cd2665 | 3.32e-07 | 13 | 25 | 3 | CID000216241 | |
| Drug | AC1L1DMQ | 4.22e-07 | 14 | 25 | 3 | CID000002418 | |
| Drug | phthalic acid | 7.87e-07 | 17 | 25 | 3 | ctd:C032279 | |
| Drug | HX600 | 9.44e-07 | 18 | 25 | 3 | CID000128016 | |
| Drug | diheptyl phthalate | 1.54e-06 | 21 | 25 | 3 | ctd:C089799 | |
| Drug | di-n-hexyl phthalate | 1.78e-06 | 22 | 25 | 3 | ctd:C027387 | |
| Drug | adapalene | 1.78e-06 | 22 | 25 | 3 | CID000060164 | |
| Drug | T0901317 | 1.78e-06 | 81 | 25 | 4 | CID000447912 | |
| Drug | Zoxazolamine [61-80-3]; Up 200; 23.8uM; PC3; HT_HG-U133A | 2.18e-06 | 198 | 25 | 5 | 6290_UP | |
| Drug | AC1L2X6Z | 3.36e-06 | 27 | 25 | 3 | CID000130325 | |
| Drug | Bexarotene | 3.47e-06 | 3 | 25 | 2 | DB00307 | |
| Drug | 2-hydroxyphytanic acid | 3.47e-06 | 3 | 25 | 2 | ctd:C002585 | |
| Drug | AC1O5SBP | 3.47e-06 | 3 | 25 | 2 | CID006439746 | |
| Drug | AGN 193109 | 5.15e-06 | 31 | 25 | 3 | CID000177238 | |
| Drug | rosavin | 5.68e-06 | 32 | 25 | 3 | ctd:C529148 | |
| Drug | CD367 | 6.24e-06 | 33 | 25 | 3 | CID000119342 | |
| Drug | Tazarotene | 6.94e-06 | 4 | 25 | 2 | DB00799 | |
| Drug | AGN 190727 | 6.94e-06 | 4 | 25 | 2 | CID006439768 | |
| Drug | DR-0 | 7.48e-06 | 35 | 25 | 3 | CID010062716 | |
| Drug | 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene | 8.15e-06 | 36 | 25 | 3 | ctd:C054919 | |
| Drug | Ro 41-5253 | 8.87e-06 | 37 | 25 | 3 | CID005312120 | |
| Drug | tazarotene | 1.12e-05 | 40 | 25 | 3 | CID000005381 | |
| Drug | 7-methoxycitronellal | 1.16e-05 | 5 | 25 | 2 | CID000019223 | |
| Drug | 13,14-dihydroretinol | 1.16e-05 | 5 | 25 | 2 | CID000446798 | |
| Drug | 7-methoxycitronellic acid | 1.16e-05 | 5 | 25 | 2 | CID000171516 | |
| Drug | 2-tert-butylphenol | 1.16e-05 | 5 | 25 | 2 | ctd:C035406 | |
| Drug | acyclic retinoid | 1.21e-05 | 41 | 25 | 3 | CID006437836 | |
| Drug | Etretinate-d3 | 1.61e-05 | 45 | 25 | 3 | CID000003312 | |
| Drug | Methoprene | 1.73e-05 | 6 | 25 | 2 | ctd:D008726 | |
| Drug | triphenyltin hydroxide | 1.73e-05 | 6 | 25 | 2 | ctd:C007567 | |
| Drug | diethyl phthalate | 1.96e-05 | 48 | 25 | 3 | ctd:C007379 | |
| Drug | di-n-pentyl phthalate | 2.35e-05 | 51 | 25 | 3 | ctd:C034171 | |
| Drug | Tretinoin | 3.23e-05 | 8 | 25 | 2 | DB00755 | |
| Drug | AC1O5JP6 | 3.23e-05 | 8 | 25 | 2 | CID006435379 | |
| Drug | Rifampin | 3.73e-05 | 356 | 25 | 5 | ctd:D012293 | |
| Drug | Propolis | 3.84e-05 | 60 | 25 | 3 | ctd:D011429 | |
| Drug | 3,5-di-tert-butylchalcone 4'-carboxylic acid | 5.18e-05 | 10 | 25 | 2 | ctd:C054189 | |
| Drug | HX 630 | 5.18e-05 | 10 | 25 | 2 | ctd:C422175 | |
| Drug | diazepinylbenzoic acid | 5.18e-05 | 10 | 25 | 2 | ctd:C438269 | |
| Drug | retinamide | 5.84e-05 | 69 | 25 | 3 | CID005370221 | |
| Drug | Musk T | 6.33e-05 | 11 | 25 | 2 | CID000061014 | |
| Drug | 9-cis-acitretin | 6.36e-05 | 71 | 25 | 3 | CID000041317 | |
| Drug | sodium cholate | 7.13e-05 | 408 | 25 | 5 | CID000000303 | |
| Drug | NSC46155 | 7.59e-05 | 12 | 25 | 2 | CID000457869 | |
| Drug | AC1L1KPQ | 8.43e-05 | 78 | 25 | 3 | CID000005602 | |
| Drug | GW2331 | 8.96e-05 | 13 | 25 | 2 | CID000657048 | |
| Drug | A-74702 | 9.09e-05 | 80 | 25 | 3 | CID000452307 | |
| Drug | AC1L9M5J | 9.31e-05 | 221 | 25 | 4 | CID000448615 | |
| Drug | benzoate | 9.31e-05 | 221 | 25 | 4 | CID000000242 | |
| Drug | Sulfonamides | 1.04e-04 | 14 | 25 | 2 | ctd:D013449 | |
| Drug | 2,4-dichlorophenol | 1.04e-04 | 14 | 25 | 2 | ctd:C004762 | |
| Drug | AC1L9K70 | 1.05e-04 | 228 | 25 | 4 | CID000446871 | |
| Drug | 5 alpha-androstane | 1.05e-04 | 84 | 25 | 3 | CID000094144 | |
| Drug | tamibarotene | 1.13e-04 | 86 | 25 | 3 | CID000108143 | |
| Drug | eq N | 1.47e-04 | 94 | 25 | 3 | CID000002126 | |
| Drug | Rodeo | 1.56e-04 | 17 | 25 | 2 | CID000038078 | |
| Drug | AC1L1GHE | 1.56e-04 | 96 | 25 | 3 | CID000003684 | |
| Drug | androst-2-en-3-ol | 1.75e-04 | 18 | 25 | 2 | CID000166036 | |
| Drug | AC1L1JLU | 1.98e-04 | 104 | 25 | 3 | CID000005098 | |
| Drug | butylbenzyl phthalate | 2.21e-04 | 108 | 25 | 3 | ctd:C027561 | |
| Drug | E-guggulsterone | 2.21e-04 | 108 | 25 | 3 | CID006439929 | |
| Drug | vitamin D3 | 2.22e-04 | 277 | 25 | 4 | CID000002735 | |
| Drug | bexarotene | 2.40e-04 | 111 | 25 | 3 | CID000082146 | |
| Drug | Teniposide | 2.40e-04 | 21 | 25 | 2 | ctd:D013713 | |
| Drug | Ro 15-0778 | 2.89e-04 | 23 | 25 | 2 | CID006436116 | |
| Drug | alitretinoin | 3.04e-04 | 301 | 25 | 4 | ctd:C103303 | |
| Drug | AC1L2E0P | 3.28e-04 | 307 | 25 | 4 | CID000019390 | |
| Drug | scoparone | 3.42e-04 | 25 | 25 | 2 | CID000008417 | |
| Drug | Prt-H | 3.70e-04 | 26 | 25 | 2 | CID003050291 | |
| Drug | sodium silicate | 4.30e-04 | 28 | 25 | 2 | CID000023266 | |
| Drug | SR-12813 | 4.61e-04 | 29 | 25 | 2 | CID000446313 | |
| Drug | fludioxonil | 4.94e-04 | 30 | 25 | 2 | ctd:C108339 | |
| Drug | Ro 41-5253 | 4.94e-04 | 30 | 25 | 2 | ctd:C084904 | |
| Drug | T0070907 | 5.28e-04 | 31 | 25 | 2 | CID002777391 | |
| Drug | Endrin | 5.63e-04 | 32 | 25 | 2 | ctd:D004732 | |
| Drug | AC1L3LFV | 5.99e-04 | 33 | 25 | 2 | CID000091134 | |
| Drug | Retinoids | 6.36e-04 | 34 | 25 | 2 | ctd:D012176 | |
| Drug | androstan-3-ol | 6.99e-04 | 160 | 25 | 3 | CID000092877 | |
| Drug | osajin | 7.13e-04 | 36 | 25 | 2 | ctd:C485800 | |
| Drug | Diosgenin | 7.13e-04 | 36 | 25 | 2 | ctd:D004144 | |
| Drug | ciglitazone | 8.19e-04 | 169 | 25 | 3 | CID000002750 | |
| Drug | vitamin D3 analog | 9.25e-04 | 41 | 25 | 2 | CID006438384 | |
| Drug | D-triiodothyronine | 9.63e-04 | 409 | 25 | 4 | CID000000861 | |
| Disease | prostate carcinoma in situ (biomarker_via_orthology) | 2.89e-06 | 4 | 21 | 2 | DOID:8634 (biomarker_via_orthology) | |
| Disease | migraine disorder | 1.07e-04 | 357 | 21 | 4 | MONDO_0005277 | |
| Disease | birth weight, pelvic organ prolapse | 5.56e-04 | 49 | 21 | 2 | EFO_0004344, EFO_0004710 | |
| Disease | Colorectal Carcinoma | 1.38e-03 | 702 | 21 | 4 | C0009402 | |
| Disease | migraine disorder, Headache | 1.70e-03 | 86 | 21 | 2 | HP_0002315, MONDO_0005277 | |
| Disease | diffuse plaque measurement | 1.82e-03 | 758 | 21 | 4 | EFO_0010699 | |
| Disease | lifestyle measurement, depressive symptom measurement | 2.52e-03 | 105 | 21 | 2 | EFO_0007006, EFO_0010724 | |
| Disease | large artery stroke | 2.91e-03 | 113 | 21 | 2 | EFO_0005524 | |
| Disease | Beta blocking agent use measurement | 2.96e-03 | 114 | 21 | 2 | EFO_0009929 | |
| Disease | prostate cancer (is_implicated_in) | 3.12e-03 | 117 | 21 | 2 | DOID:10283 (is_implicated_in) | |
| Disease | Alzheimer's disease (is_implicated_in) | 3.94e-03 | 132 | 21 | 2 | DOID:10652 (is_implicated_in) | |
| Disease | ascending aortic diameter | 4.42e-03 | 140 | 21 | 2 | EFO_0021787 | |
| Disease | mean arterial pressure | 5.10e-03 | 499 | 21 | 3 | EFO_0006340 | |
| Disease | hematocrit | 5.15e-03 | 1011 | 21 | 4 | EFO_0004348 | |
| Disease | Paroxysmal atrial fibrillation | 5.46e-03 | 156 | 21 | 2 | C0235480 | |
| Disease | Persistent atrial fibrillation | 5.46e-03 | 156 | 21 | 2 | C2585653 | |
| Disease | familial atrial fibrillation | 5.46e-03 | 156 | 21 | 2 | C3468561 | |
| Disease | Atrial Fibrillation | 5.73e-03 | 160 | 21 | 2 | C0004238 | |
| Disease | Mammary Neoplasms, Human | 5.87e-03 | 525 | 21 | 3 | C1257931 | |
| Disease | Mammary Carcinoma, Human | 5.87e-03 | 525 | 21 | 3 | C4704874 | |
| Disease | Mammary Neoplasms | 5.93e-03 | 527 | 21 | 3 | C1458155 | |
| Disease | circadian rhythm | 5.94e-03 | 163 | 21 | 2 | EFO_0004354 | |
| Disease | Breast Carcinoma | 6.28e-03 | 538 | 21 | 3 | C0678222 | |
| Disease | Malignant neoplasm of breast | 6.37e-03 | 1074 | 21 | 4 | C0006142 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KVTRNRCQYCRLQKC | 136 | P13631 | |
| YNIICKKCRADRRSC | 356 | P54762 | |
| NRRKSCQACRLRKCY | 196 | Q92731 | |
| CNSRRCKKTFRQCSN | 2561 | Q07954 | |
| CKKTFRQCSNGRCVS | 2566 | Q07954 | |
| ADRCTKRYGRCKRDC | 26 | Q30KQ6 | |
| ACGKIVCRNCSRNKY | 1266 | Q6ZNL6 | |
| QCEKYRRCKQCQRRT | 616 | Q6ZN84 | |
| TCRSGQKRRNCCYKT | 431 | Q5T890 | |
| YGKCRNTIGSFKCRC | 1086 | P35556 | |
| RRCYYGTGRCRKSCK | 36 | Q30KQ5 | |
| KRQRNRCQYCRYQKC | 181 | P19793 | |
| QIGKCSTRGRKCCRR | 51 | P81534 | |
| RKQRNRCQYCRLLKC | 106 | Q15406 | |
| CCFCLYRKSCRRRTG | 46 | O00445 | |
| RAYAGCTQRTSKACR | 86 | Q6NW40 | |
| RCSQCRVAKYCSAKC | 61 | Q9H7B4 | |
| KRQRNRCQYCRYQKC | 251 | P28702 | |
| TCGCRESYICKVNRK | 721 | Q9Y4E5 | |
| KRCTRCYRVGYCNQL | 806 | O94966 | |
| LRKNCCTSVRRYECS | 136 | Q9HAH1 | |
| CTSVRRYECSQCGKL | 141 | Q9HAH1 | |
| SCVLQNGSYRCKCRD | 726 | Q5GFL6 | |
| QQRCKNSIGSYKCSC | 191 | Q96DN2 | |
| RRYKCNECGKAFRTC | 421 | Q76KX8 | |
| CKKCGRRFGRLSNCT | 366 | P98182 | |
| RCQLCKYFCSTRKGI | 1661 | Q96JM2 |